Literature DB >> 28472504

Exploring background mutational processes to decipher cancer genetic heterogeneity.

Alexander Goncearenco1, Stephanie L Rager1,2, Minghui Li1, Qing-Xiang Sang3, Igor B Rogozin1, Anna R Panchenko1.   

Abstract

Much remains unknown about the progression and heterogeneity of mutational processes in different cancers and their diagnostic and clinical potential. A growing body of evidence supports mutation rate dependence on the local DNA sequence context for various types of mutations. We propose several tools for the analysis of cancer context-dependent mutations, which are implemented in an online computational framework MutaGene. The framework explores DNA context-dependent mutational patterns and underlying somatic cancer mutagenesis, analyzes mutational profiles of cancer samples, identifies the combinations of underlying mutagenic processes including those related to infidelity of DNA replication and repair machinery, and various other endogenous and exogenous mutagenic factors. As a result, the combination of mutagenic processes can be identified in any query sample with subsequent comparison to mutational profiles derived from malignant and benign samples. In addition, mutagen or cancer-specific mutational background models are applied to calculate expected DNA and protein site mutability to decouple relative contributions of mutagenesis and selection in carcinogenesis, thus elucidating the site-specific driving events in cancer. MutaGene is freely available at https://www.ncbi.nlm.nih.gov/projects/mutagene/. Published by Oxford University Press on behalf of Nucleic Acids Research 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28472504      PMCID: PMC5793731          DOI: 10.1093/nar/gkx367

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  Phylogenetic estimation of context-dependent substitution rates by maximum likelihood.

Authors:  Adam Siepel; David Haussler
Journal:  Mol Biol Evol       Date:  2003-12-05       Impact factor: 16.240

2.  Computational approaches to identify functional genetic variants in cancer genomes.

Authors:  Abel Gonzalez-Perez; Ville Mustonen; Boris Reva; Graham R S Ritchie; Pau Creixell; Rachel Karchin; Miguel Vazquez; J Lynn Fink; Karin S Kassahn; John V Pearson; Gary D Bader; Paul C Boutros; Lakshmi Muthuswamy; B F Francis Ouellette; Jüri Reimand; Rune Linding; Tatsuhiro Shibata; Alfonso Valencia; Adam Butler; Serge Dronov; Paul Flicek; Nick B Shannon; Hannah Carter; Li Ding; Chris Sander; Josh M Stuart; Lincoln D Stein; Nuria Lopez-Bigas
Journal:  Nat Methods       Date:  2013-08       Impact factor: 28.547

Review 3.  On the origin of G --> T transversions in lung cancer.

Authors:  Gerd P Pfeifer; Pierre Hainaut
Journal:  Mutat Res       Date:  2003-05-15       Impact factor: 2.433

4.  The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection.

Authors:  Vinod Kumar Yadav; James DeGregori; Subhajyoti De
Journal:  Nucleic Acids Res       Date:  2016-02-15       Impact factor: 16.971

Review 5.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

6.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

7.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

8.  SomaticSignatures: inferring mutational signatures from single-nucleotide variants.

Authors:  Julian S Gehring; Bernd Fischer; Michael Lawrence; Wolfgang Huber
Journal:  Bioinformatics       Date:  2015-07-10       Impact factor: 6.937

Review 9.  Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

Authors:  M Hollstein; L B Alexandrov; C P Wild; M Ardin; J Zavadil
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

10.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

View more
  26 in total

1.  Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation.

Authors:  Karoliina Stefanius; Kelly Servage; Marcela de Souza Santos; Hillery Fields Gray; Jason E Toombs; Suneeta Chimalapati; Min S Kim; Venkat S Malladi; Rolf Brekken; Kim Orth
Journal:  Elife       Date:  2019-05-28       Impact factor: 8.140

2.  Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures.

Authors:  Jongkeun Lee; Andy Jinseok Lee; June-Koo Lee; Jongkeun Park; Youngoh Kwon; Seongyeol Park; Hyonho Chun; Young Seok Ju; Dongwan Hong
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

3.  DNA polymerase η mutational signatures are found in a variety of different types of cancer.

Authors:  Igor B Rogozin; Alexander Goncearenco; Artem G Lada; Subhajyoti De; Vyacheslav Yurchenko; German Nudelman; Anna R Panchenko; David N Cooper; Youri I Pavlov
Journal:  Cell Cycle       Date:  2018-02-15       Impact factor: 4.534

4.  Detecting presence of mutational signatures in cancer with confidence.

Authors:  Xiaoqing Huang; Damian Wojtowicz; Teresa M Przytycka
Journal:  Bioinformatics       Date:  2018-01-15       Impact factor: 6.937

Review 5.  Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.

Authors:  Hanane Omichessan; Gianluca Severi; Vittorio Perduca
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

6.  Engineering Forward Genetics into Cultured Cancer Cells for Chemical Target Identification.

Authors:  Juan Manuel Povedano; Joel Liou; David Wei; Ashwin Srivatsav; Jiwoong Kim; Yang Xie; Deepak Nijhawan; David G McFadden
Journal:  Cell Chem Biol       Date:  2019-07-11       Impact factor: 8.116

7.  A phylogenetic approach to study the evolution of somatic mutational processes in cancer.

Authors:  Sayaka Miura; Tracy Vu; Jiyeong Choi; Jeffrey P Townsend; Sajjad Karim; Sudhir Kumar
Journal:  Commun Biol       Date:  2022-06-22

Review 8.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

9.  Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.

Authors:  Peter Georgeson; Bernard J Pope; Christophe Rosty; Mark Clendenning; Khalid Mahmood; Jihoon E Joo; Romy Walker; Ryan A Hutchinson; Susan Preston; Julia Como; Sharelle Joseland; Aung Ko Win; Finlay A Macrae; John L Hopper; Dmitri Mouradov; Peter Gibbs; Oliver M Sieber; Dylan E O'Sullivan; Darren R Brenner; Steve Gallinger; Mark A Jenkins; Ingrid M Winship; Daniel D Buchanan
Journal:  Gut       Date:  2021-01-07       Impact factor: 23.059

10.  DNA Methylation, Deamination, and Translesion Synthesis Combine to Generate Footprint Mutations in Cancer Driver Genes in B-Cell Derived Lymphomas and Other Cancers.

Authors:  Igor B Rogozin; Abiel Roche-Lima; Kathrin Tyryshkin; Kelvin Carrasquillo-Carrión; Artem G Lada; Lennard Y Poliakov; Elena Schwartz; Andreu Saura; Vyacheslav Yurchenko; David N Cooper; Anna R Panchenko; Youri I Pavlov
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.